Vela Diagnostics launches it’s first Sample-to-Result Sentosa® Liberty NGS Workflow* for Oncology, targeted at existing Illumina’s MiSeq users

Singapore (June 11, 2018) – Vela Diagnostics announced today that the Sentosa® Liberty Next-Generation Sequencing (NGS) – based Workflow*, is now available for early access customers. The workflow is compatible with Illumina’s MiSeq instrument and provides a Sample-to-Result solution, including data interpretation and reporting. 

The new sample-to-result workflow delivers an immediate advantage of the front-end automation to the existing MiSeq users, enabling them to optimize extraction and sample preparation; and provides menu expansion through the existing Sentosa^® NGS panels.

With the front-end automation and streamlined reporting, users can move to the next steps more quickly. In the workflow, the Sentosa^® SX101 instrument is used for automated extraction and NGS library preparation. The downstream reporting is enabled on the Sentosa^® SQ Reporter, where data can be transmitted through direct connectivity or FASTQ file integration, depending on the workflow configuration.

The Sentosa® SQ OncoKey Focus Panel* is the first panel available on the Sentosa® Liberty*, making it the first panel compatible with a third-party sequencer in the Vela portfolio; more panels are going to be developed going forward.

The Sentosa® SQ OncoKey Focus Panel* delivers accuracy in the detection of hotspot mutations (SNVs, indels) from 30 targeted genes that are important to non-small cell lung cancer (NSCLC) and colorectal cancer (CRC), from formalin-fixed paraffin-embedded (FFPE) samples. 

Using the Vela’s Sentosa® SQ OncoKey Focus* next-generation sequencing panel, researchers now have an opportunity to streamline laboratory operations and are offered more choice when it comes to determining the relevancy of the hotspot mutations.

In addition, Vela offers Sentosa^® SX101 Open Channel capability with easy-to-implement walk away automation with pre-defined and customized applications for a number of third-party reagents and a wide range of pipetting protocols; e.g. sample extraction, PCR setup and NGS library preparation,  Sanger sequencing Big Dye cleanup and many more. 

*For Research Use Only. Not for use in diagnostic procedures.